Dietary Supplement
NAD+
NAD+ is a dietary supplement with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_2
1
25%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Active, not recruiting1
Recruiting1
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)
Trials by Status
active_not_recruiting125%
recruiting125%
not_yet_recruiting125%
completed125%
Recent Activity
2 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults
NCT07692633
active_not_recruitingphase_3
Combination Gerotherapeutic Interventions for Healthspan Improvement
NCT07475546
recruitingnot_applicable
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
NCT06919328
completedphase_2
Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
NCT04604704
Clinical Trials (4)
Showing 4 of 4 trials
NCT07692633Not Applicable
A Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults
NCT07475546Phase 3
Combination Gerotherapeutic Interventions for Healthspan Improvement
NCT06919328Not Applicable
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
NCT04604704Phase 2
Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4